These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 4640313
1. Bone healing in multiple myeloma with melphalan chemotherapy. Rodriguez LH, Finkelstein JB, Shullenberger CC, Alexanian R. Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313 [No Abstract] [Full Text] [Related]
3. Combination chemotherapy for multiple myeloma. Alexanian R, Bonnet J, Gehan E, Haut A, Hewlett J, Lane M, Monto R, Wilson H. Cancer; 1972 Aug; 30(2):382-9. PubMed ID: 5051662 [No Abstract] [Full Text] [Related]
4. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine. Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464 [Abstract] [Full Text] [Related]
5. [Therapeutic experiences in multiple myeloma]. Sonntag R, Favre E, Martz G. Schweiz Med Wochenschr; 1972 Nov 04; 102(44):1588-9. PubMed ID: 4566555 [No Abstract] [Full Text] [Related]
6. Multiple myeloma. II. The value of melphalan. Bernard DB, Lynch SR, Bothwell TH, Bezwoda WR, Stevens K, Shulman G. S Afr Med J; 1974 May 18; 48(24):1026-8. PubMed ID: 4835772 [No Abstract] [Full Text] [Related]
7. The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma. Cuttner J, Wasserman LR, Martz G, Sonntag RW, Kyle RA, Silver RT, Spurr C, Harley JB, Wiernik PM, Cornwell GG, Falkson G, Glidewell O, Holland JF. Med Pediatr Oncol; 1975 May 18; 1(3):207-16. PubMed ID: 1232529 [Abstract] [Full Text] [Related]
8. Steroid therapy of multiple myeloma and macroglobulinemia. Hoogstraten B. Med Clin North Am; 1973 Sep 18; 57(5):1321-30. PubMed ID: 4366516 [No Abstract] [Full Text] [Related]
9. [A further case of myeloma with paraprotein showing antistreptolysin O activity (unusual visceral signs, radiological regression under treatment]. Sauvezie B, Missioux D, Leroy V, Wahl D, Goumy P, Bussière JL, Rampon S. Rev Rhum Mal Osteoartic; 1974 Jun 18; 41(6):449-53. PubMed ID: 4425245 [No Abstract] [Full Text] [Related]
10. The treatment of plasma cell myeloma. Bergsagel DE. Br J Haematol; 1976 Aug 18; 33(4):443-9. PubMed ID: 795453 [No Abstract] [Full Text] [Related]
11. Vindesine in refractory multiple myeloma. van der Lelie H, Monasch E, Pegels HG, von dem Borne AE. Cancer; 1986 Jan 15; 57(2):226-9. PubMed ID: 3942957 [Abstract] [Full Text] [Related]
12. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. Bergsagel DE, Cowan DH, Hasselback R. Can Med Assoc J; 1972 Nov 04; 107(9):851-5. PubMed ID: 4653931 [Abstract] [Full Text] [Related]
13. Plasma cell myeloma. An interpretive review. Bergsagel DE. Cancer; 1972 Dec 04; 30(6):1588-94. PubMed ID: 4565818 [No Abstract] [Full Text] [Related]
14. Multiple myeloma without detectable Ig synthesis. Ferraris AM, Haupt E, Ratti M. Acta Haematol; 1979 Dec 04; 62(5-6):257-61. PubMed ID: 121666 [Abstract] [Full Text] [Related]
15. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol). Case DC, Sonneborn HL, Paul SD, Hayes DM, Dorsk BM, Carroll RJ, Bove L. Oncology; 1985 Dec 04; 42(3):137-40. PubMed ID: 3858763 [Abstract] [Full Text] [Related]